# Scott Magargee

> Scott Magargee is the CEO and co-founder of Springbok Analytics, a Charlottesville, Virginia company that turns ordinary MRI scans into FDA-cleared, AI-built 3D maps of every muscle in the human body. A former Princeton history major and Top 100 law firm litigator, he traded courtrooms for muscle health, joining the University of Virginia spinout in December 2019 and steering it through a $5M oversubscribed Series A in January 2025 backed by the NBA. Under his watch, Springbok has scanned elite athletes, pro basketball leagues, and clinical-trial patients, chasing a single idea: make muscle visible, measurable, and actionable.

- **Role:** CEO & Co-Founder at Springbok Analytics
- **Organizations:** Springbok Analytics, American Energy Society, Friends of FSH Research, Metis Genetics, LLC, Locus Health
- **Nationality:** American
- **Education:** AB in History, Princeton University, JD (Juris Doctor), University of Richmond School of Law
- **Known for:** Led Springbok Analytics to FDA clearance for its AI muscle-analysis technology, Closed an oversubscribed $5M Series A in January 2025 with the NBA among investors, Built partnerships spanning pro sports (Unrivaled Basketball, Proactive Sports Performance) and biotech clinical trials (Epicrispr FSHD study)

## Career timeline

- **Earlier career** — Partner at a Top 100 Philadelphia law firm, focused on government investigations, criminal and civil litigation, and regulatory matters
- **Earlier career** — Co-founded the American Energy Society, a professional association advancing affordable and safe energy
- **Health tech ventures** — Led business development at Metis Genetics and served as Senior Vice President at Locus Health
- **2019** — Joined Springbok Analytics as CEO & Co-Founder (December 2019)
- **2023** — Springbok raised a $3M seed round for its AI-powered muscle analysis
- **2024** — Springbok received FDA clearance (K241331); appointed Dr. Andy Galpin to its advisory board
- **2025** — Closed an oversubscribed $5M Series A led by Transition Equity Partners with NBA participation; scanned all 36 Unrivaled Basketball athletes; launched precision body composition analysis

## Achievements

- Led Springbok Analytics to FDA clearance for its AI muscle-analysis technology
- Closed an oversubscribed $5M Series A in January 2025 with the NBA among investors
- Built partnerships spanning pro sports (Unrivaled Basketball, Proactive Sports Performance) and biotech clinical trials (Epicrispr FSHD study)
- Commercialized 15+ years of University of Virginia muscle-imaging research
- Co-founded the American Energy Society earlier in his career

## Latest updates

- **2025-01** — Springbok Analytics announced an oversubscribed $5M Series A led by Transition Equity Partners with participation from the NBA and others.
- **2025-03** — Springbok led MRI innovations in a multi-site pediatric FSHD clinical study.
- **2025** — Company launched precision body composition analysis from rapid MRI scans.

## Links

- Website: https://springbokanalytics.com
- LinkedIn: http://www.linkedin.com/in/scott-magargee-0232b753
- Twitter/X: https://twitter.com/springboktech

---

Profile page: https://yespress.io/scott-magargee
Published by YesPress — https://yespress.io
Last updated: 2026-06-20